# Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection

> **NCT03352349** · PHASE2 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Portal Vein Pressure

## Interventions

- **DRUG:** Terlipressinum

## Key facts

- **NCT ID:** NCT03352349
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03352349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03352349, "Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03352349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*